(133) found that PHGDH can not only participate in serine biosynthesis in TCs, but more importantly, can regulate the Sox2-Oct4 complex, a core stemness transcription factor that drives the progression and recurrence of TCs, and so may represent a possible target for thyroid cancer treatment. Here, POU5F1 is linked to thyroid cancer.